The Recall Desk
ModerateFDA (Devices)·Z-2084-2023·Announced 2023-07-12

Collagen matrix recalled for endotoxin testing methodology issues

TEI Biosciences recalled 665 units of Revize-X collagen matrix nationwide due to possible out-of-specification endotoxin test results caused by issues with the company's testing procedures. No illnesses have been reported.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: This FDA Class II device recall involves testing methodology failures with no reported illnesses, injuries, or confirmed product contamination. The recall is precautionary based on gaps in endotoxin testing procedures rather than a confirmed product defect.

Plain-English summary

Revize-X is a collagen matrix medical device used for soft tissue reconstruction. TEI Biosciences recalled 665 units of the product due to possible out-of-specification endotoxin test results. The recall resulted from issues with the company's in-process and finished goods endotoxin testing procedures.

Affected units were distributed nationwide in two sizes (12x6 cm and 10x9 cm). The product is available by prescription only.

No illnesses or injuries have been reported in connection with this recall. Healthcare providers and patients who have received this product should consult their healthcare provider for guidance regarding any concerns.

The recalled product

Product
Revize-X; Collagen Matrix for Soft Tissue Reconstruction; Rx Only; Sizes 12x6 cm and 10x9 cm.
Manufacturer
TEI Biosciences, Inc.
Hazard
  • endotoxin
  • testing-failure

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • Item No. (UDI-DI): 611-005-001 (10381780357308)
  • 611-005-002 (10381780357315).

Distribution

Distributed nationwide across the United States.